NCT03871439View on ClinicalTrials.gov

OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 13, 2019

Primary Completion Date

May 8, 2019

Study Completion Date

May 8, 2019

Conditions
Healthy
Interventions
DRUG

PF-05221304 Formulation A

50mg

DRUG

PF-05221304 Formulation B

50mg

Trial Locations (1)

06511

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03871439 - OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS | Biotech Hunter | Biotech Hunter